AMGEN INC (AMGN)
Clinical trial NCT06613100 updates: 1. completion date: 2030-01-23 → 2030-03-04 2. primary completion date: 2027-01-22 → 2027-02-17
Clinical trial NCT06613100 updates: 1. completion date: 2030-01-23 → 2030-03-04 2. primary completion date: 2027-01-22 → 2027-02-17
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical